Just diagnosed with Triple-Negative Breast Cancer — what should I do first
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Your First Steps After a Triple-Negative Breast Cancer Diagnosis
I'm sorry you're facing this diagnosis. Here's what you should prioritize right now, based on expert guidance for triple-negative breast cancer patients:
1. Understand Your Specific Tumor Profile (This is Critical for TNBC)
Triple-negative breast cancer is called "triple-negative" because it lacks three receptors (estrogen, progesterone, and HER2) that many other breast cancers have. This means hormone therapy won't work for you, but it also means your treatment path is different—and there are important tests that can guide better decisions.
Key tests to request immediately:
According to the CancerPatientLab webinar "An MD PhD Navigates Breast Cancer" by Dr. [removed] Lopez-Correa, MD, PhD, you should ask your oncologist about:
- Oncotype DX test - analyzes your tumor tissue to help determine if you need chemotherapy and assess your recurrence risk
- Whole genome sequencing (NGS) of your tumor tissue - provides comprehensive analysis of specific mutations in YOUR cancer. This is especially important for TNBC because it can reveal actionable mutations that standard tests might miss
- BRCA1/BRCA2 genetic testing - triple-negative patients under 60 should especially consider this, as BRCA mutations are more common in TNBC and affect treatment options and family risk
- Ki-67 test - measures how fast your tumor cells are dividing
Why this matters for TNBC: Dr. [removed]-Correa's experience shows that whole genome sequencing can reveal mutations (like AKT1) that aren't caught by standard tests but can change treatment recommendations—such as whether CDK4/6 inhibitors might help you.
2. Get a Second Opinion and Ask the Right Questions
Don't rush into treatment decisions. According to the webinar guidance, you should:
- Meet with at least one additional oncologist to discuss your pathology results
- Ask each doctor: "Given my specific tumor profile, what treatment would you recommend and why?"
- Request time to discuss test results thoroughly—don't accept a quick summary
Questions to ask your oncologist:
- "What is my tumor's stage, and what does that mean for my treatment?"
- "Have you done (or can you do) whole genome sequencing on my tumor tissue?"
- "Do I have any actionable mutations that might change my treatment approach?"
- "What are my chemotherapy options, and what are the pros and cons of each?"
- "Are there clinical trials I might be eligible for based on my tumor profile?"
- "What is my recurrence risk based on my specific findings?"
3. Seek Genetic Counseling
According to Dr. [removed]-Correa's guidance, genetic counseling is important for triple-negative patients because:
- It helps you understand BRCA testing results and what they mean for you and your family
- It clarifies which tests are truly necessary versus "nice to know"
- A genetic counselor can help you navigate insurance coverage and out-of-pocket costs
4. Understand the Treatment Timeline
Important: Dr. [removed]-Correa emphasizes that once you're diagnosed with cancer, you have roughly a 2-week window to make treatment decisions and begin therapy. Cancer grows continuously, so while you should get second opinions and understand your options, you also need to move forward relatively quickly.
This doesn't mean panic—it means being organized and decisive.
5. Advocate for Comprehensive Testing
The webinar emphasizes: Don't be afraid to push for additional testing. Some important points:
- Not all tests are standard of care, but that doesn't mean they aren't valuable for YOUR case
- If your doctor says "we won't change treatment based on that test," ask why—sometimes additional information helps with monitoring and surveillance even if initial treatment stays the same
- If cost is a barrier, ask about payment plans or whether you can access testing through research programs
6. Connect with Support and Information
- Reach out to patient advocacy groups focused on triple-negative breast cancer
- Consider connecting with other TNBC patients who can share their experiences
- Ask your oncology team about nurse navigators or patient advocates who can help coordinate your care
7. **Gather Your [ID removed]
- Request copies of your pathology report, imaging (mammogram, ultrasound, any MRI), and any genetic testing results
- Keep organized copies—you may want to share these with a second opinion doctor or bring them to appointments
Why This Matters for Triple-Negative Breast Cancer Specifically
Triple-negative breast cancer tends to be more aggressive than some other types, but it also responds well to chemotherapy when used appropriately. The key is understanding YOUR specific tumor's characteristics so your oncologist can tailor treatment to you—not just give you a standard protocol.
As Dr. [removed]-Correa notes in her experience: "Your cancer journey is unique, and personalized genomic information can help tailor your treatment."
Next Steps This Week
- Request your full pathology report (not just the summary)
- Schedule a consultation with a genetic counselor
- Ask your oncologist about whole genome sequencing if it hasn't been done
- Schedule a second opinion appointment
- Write down your questions before each appointment
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Triple-Negative Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: